NO324312B1 - Sammensetning, morsmelkerstatning samt fremgangsmate og anvendelse av nevnte sammensetning. - Google Patents

Sammensetning, morsmelkerstatning samt fremgangsmate og anvendelse av nevnte sammensetning. Download PDF

Info

Publication number: NO324312B1
Authority: NO; Norway
Prior art keywords: protein; weight; composition according; arginine; histidine
Prior art date: 1999-04-29

Application number

NO20015178A

Other languages

English (en)

Norwegian (no)

Other versions

NO20015178L (no

NO20015178D0 (no

Inventor

Marie-Christine Secretin

Niklaus Meister

Olivier Ballevre

Jean-Claude Maire

Ferdinand Haschke

Zdenek Kratky

Rolf Jost

Martinas Kuslys

Original Assignee

Nestle Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-29

Filing date

2001-10-23

Publication date

2007-09-24

1999-04-29 Priority claimed from EP99108405A external-priority patent/EP1048226B1/fr

1999-09-29 Priority claimed from GBGB9923048.4A external-priority patent/GB9923048D0/en

2001-10-23 Application filed by Nestle Sa filed Critical Nestle Sa

2001-10-23 Publication of NO20015178L publication Critical patent/NO20015178L/no

2001-10-23 Publication of NO20015178D0 publication Critical patent/NO20015178D0/no

2007-09-24 Publication of NO324312B1 publication Critical patent/NO324312B1/no

Links

239000000203 mixture Substances 0.000 title claims description 80
235000013350 formula milk Nutrition 0.000 title claims description 26
238000000034 method Methods 0.000 title claims description 11
235000018102 proteins Nutrition 0.000 claims description 91
102000004169 proteins and genes Human genes 0.000 claims description 91
108090000623 proteins and genes Proteins 0.000 claims description 91
108010046377 Whey Proteins Proteins 0.000 claims description 50
102000007544 Whey Proteins Human genes 0.000 claims description 48
235000020256 human milk Nutrition 0.000 claims description 44
210000004251 human milk Anatomy 0.000 claims description 44
235000009508 confectionery Nutrition 0.000 claims description 33
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 29
239000004475 Arginine Substances 0.000 claims description 26
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 26
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 26
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 26
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 25
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 25
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 20
239000004472 Lysine Substances 0.000 claims description 20
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 20
235000021119 whey protein Nutrition 0.000 claims description 20
235000014633 carbohydrates Nutrition 0.000 claims description 16
150000001720 carbohydrates Chemical class 0.000 claims description 16
150000002632 lipids Chemical class 0.000 claims description 16
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 14
108010076119 Caseins Proteins 0.000 claims description 13
102000011632 Caseins Human genes 0.000 claims description 13
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 13
239000004473 Threonine Substances 0.000 claims description 13
239000008101 lactose Substances 0.000 claims description 13
102000014171 Milk Proteins Human genes 0.000 claims description 7
108010011756 Milk Proteins Proteins 0.000 claims description 7
235000016709 nutrition Nutrition 0.000 claims description 7
235000021239 milk protein Nutrition 0.000 claims description 5
235000006180 nutrition needs Nutrition 0.000 claims description 5
238000004519 manufacturing process Methods 0.000 claims description 4
238000002156 mixing Methods 0.000 claims description 4
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
239000003814 drug Substances 0.000 claims description 3
239000005905 Hydrolysed protein Substances 0.000 claims description 2
150000003626 triacylglycerols Chemical class 0.000 claims 1
239000005862 Whey Substances 0.000 description 30
150000001413 amino acids Chemical class 0.000 description 22
229960002885 histidine Drugs 0.000 description 21
229960004799 tryptophan Drugs 0.000 description 20
235000009697 arginine Nutrition 0.000 description 18
229960003121 arginine Drugs 0.000 description 18
229940024606 amino acid Drugs 0.000 description 17
235000001014 amino acid Nutrition 0.000 description 17
229960004441 tyrosine Drugs 0.000 description 17
239000000243 solution Substances 0.000 description 13
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
229910052500 inorganic mineral Inorganic materials 0.000 description 11
239000011707 mineral Substances 0.000 description 11
235000010755 mineral Nutrition 0.000 description 11
239000007788 liquid Substances 0.000 description 9
230000008901 benefit Effects 0.000 description 8
238000006460 hydrolysis reaction Methods 0.000 description 7
230000000774 hypoallergenic effect Effects 0.000 description 7
229940088594 vitamin Drugs 0.000 description 7
229930003231 vitamin Natural products 0.000 description 7
235000013343 vitamin Nutrition 0.000 description 7
239000011782 vitamin Substances 0.000 description 7
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
239000005018 casein Substances 0.000 description 6
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 6
235000021240 caseins Nutrition 0.000 description 6
230000007062 hydrolysis Effects 0.000 description 6
229940057917 medium chain triglycerides Drugs 0.000 description 6
229910052757 nitrogen Inorganic materials 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
235000020247 cow milk Nutrition 0.000 description 5
239000007787 solid Substances 0.000 description 5
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 4
229930064664 L-arginine Natural products 0.000 description 4
235000014852 L-arginine Nutrition 0.000 description 4
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
230000000903 blocking effect Effects 0.000 description 4
235000019197 fats Nutrition 0.000 description 4
230000014759 maintenance of location Effects 0.000 description 4
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
239000011541 reaction mixture Substances 0.000 description 4
235000010469 Glycine max Nutrition 0.000 description 3
206010020751 Hypersensitivity Diseases 0.000 description 3
108010019160 Pancreatin Proteins 0.000 description 3
AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 3
239000000920 calcium hydroxide Substances 0.000 description 3
229910001861 calcium hydroxide Inorganic materials 0.000 description 3
235000011116 calcium hydroxide Nutrition 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
239000003995 emulsifying agent Substances 0.000 description 3
230000029142 excretion Effects 0.000 description 3
238000009472 formulation Methods 0.000 description 3
238000004108 freeze drying Methods 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
239000003921 oil Substances 0.000 description 3
235000019198 oils Nutrition 0.000 description 3
229940055695 pancreatin Drugs 0.000 description 3
230000008569 process Effects 0.000 description 3
239000006188 syrup Substances 0.000 description 3
235000020357 syrup Nutrition 0.000 description 3
230000002485 urinary effect Effects 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
102100021935 C-C motif chemokine 26 Human genes 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
239000005913 Maltodextrin Substances 0.000 description 2
229920002774 Maltodextrin Polymers 0.000 description 2
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
235000019485 Safflower oil Nutrition 0.000 description 2
235000019486 Sunflower oil Nutrition 0.000 description 2
240000008042 Zea mays Species 0.000 description 2
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
235000002017 Zea mays subsp mays Nutrition 0.000 description 2
239000002253 acid Substances 0.000 description 2
MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
125000000129 anionic group Chemical group 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000011575 calcium Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
239000004202 carbamide Substances 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
235000008504 concentrate Nutrition 0.000 description 2
238000001816 cooling Methods 0.000 description 2
235000005822 corn Nutrition 0.000 description 2
GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
229940079593 drug Drugs 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
229940035034 maltodextrin Drugs 0.000 description 2
235000012054 meals Nutrition 0.000 description 2
239000002207 metabolite Substances 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
238000001471 micro-filtration Methods 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
239000000843 powder Substances 0.000 description 2
239000000047 product Substances 0.000 description 2
239000003531 protein hydrolysate Substances 0.000 description 2
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
239000003813 safflower oil Substances 0.000 description 2
235000005713 safflower oil Nutrition 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000002600 sunflower oil Substances 0.000 description 2
XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
238000000108 ultra-filtration Methods 0.000 description 2
MUVQIIBPDFTEKM-IUYQGCFVSA-N (2r,3s)-2-aminobutane-1,3-diol Chemical compound C[C@H](O)[C@H](N)CO MUVQIIBPDFTEKM-IUYQGCFVSA-N 0.000 description 1
OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
206010067484 Adverse reaction Diseases 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
244000197960 Galium verum Species 0.000 description 1
235000000911 Galium verum Nutrition 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
102000010445 Lactoferrin Human genes 0.000 description 1
108010063045 Lactoferrin Proteins 0.000 description 1
201000010538 Lactose Intolerance Diseases 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
239000005642 Oleic acid Substances 0.000 description 1
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
235000019482 Palm oil Nutrition 0.000 description 1
235000021314 Palmitic acid Nutrition 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
206010036590 Premature baby Diseases 0.000 description 1
108010009736 Protein Hydrolysates Proteins 0.000 description 1
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
238000010793 Steam injection (oil industry) Methods 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
102000005158 Subtilisins Human genes 0.000 description 1
108010056079 Subtilisins Proteins 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
229930003779 Vitamin B12 Natural products 0.000 description 1
229930003471 Vitamin B2 Natural products 0.000 description 1
229930003268 Vitamin C Natural products 0.000 description 1
229930003316 Vitamin D Natural products 0.000 description 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
229930003427 Vitamin E Natural products 0.000 description 1
229930003448 Vitamin K Natural products 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000006838 adverse reaction Effects 0.000 description 1
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
239000013566 allergen Substances 0.000 description 1
208000030961 allergic reaction Diseases 0.000 description 1
235000020661 alpha-linolenic acid Nutrition 0.000 description 1
DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
235000021342 arachidonic acid Nutrition 0.000 description 1
229940114079 arachidonic acid Drugs 0.000 description 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
238000010241 blood sampling Methods 0.000 description 1
229960005069 calcium Drugs 0.000 description 1
239000000828 canola oil Substances 0.000 description 1
235000019519 canola oil Nutrition 0.000 description 1
108010067454 caseinomacropeptide Proteins 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000005341 cation exchange Methods 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
230000008859 change Effects 0.000 description 1
235000013351 cheese Nutrition 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
229960001231 choline Drugs 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
229910052804 chromium Inorganic materials 0.000 description 1
239000011651 chromium Substances 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical class OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
229960002173 citrulline Drugs 0.000 description 1
235000013477 citrulline Nutrition 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
239000003240 coconut oil Substances 0.000 description 1
235000019864 coconut oil Nutrition 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
235000020205 cow's milk formula Nutrition 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
230000003467 diminishing effect Effects 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
235000020669 docosahexaenoic acid Nutrition 0.000 description 1
229940090949 docosahexaenoic acid Drugs 0.000 description 1
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
238000001035 drying Methods 0.000 description 1
235000013345 egg yolk Nutrition 0.000 description 1
210000002969 egg yolk Anatomy 0.000 description 1
235000020776 essential amino acid Nutrition 0.000 description 1
239000003797 essential amino acid Substances 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
238000011049 filling Methods 0.000 description 1
235000021323 fish oil Nutrition 0.000 description 1
229960000304 folic acid Drugs 0.000 description 1
235000019152 folic acid Nutrition 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
-1 for example Chemical compound 0.000 description 1
239000012458 free base Substances 0.000 description 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
230000037219 healthy weight Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
229960000367 inositol Drugs 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
235000021242 lactoferrin Nutrition 0.000 description 1
229940078795 lactoferrin Drugs 0.000 description 1
229960004488 linolenic acid Drugs 0.000 description 1
KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
108010009355 microbial metalloproteinases Proteins 0.000 description 1
235000021243 milk fat Nutrition 0.000 description 1
229910052750 molybdenum Inorganic materials 0.000 description 1
239000011733 molybdenum Substances 0.000 description 1
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
229960003512 nicotinic acid Drugs 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
229960002446 octanoic acid Drugs 0.000 description 1
229960002969 oleic acid Drugs 0.000 description 1
235000021313 oleic acid Nutrition 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
235000020660 omega-3 fatty acid Nutrition 0.000 description 1
239000003346 palm kernel oil Substances 0.000 description 1
235000019865 palm kernel oil Nutrition 0.000 description 1
239000002540 palm oil Substances 0.000 description 1
229940098695 palmitic acid Drugs 0.000 description 1
229940055726 pantothenic acid Drugs 0.000 description 1
235000019161 pantothenic acid Nutrition 0.000 description 1
239000011713 pantothenic acid Substances 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
230000002028 premature Effects 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
235000021075 protein intake Nutrition 0.000 description 1
RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
235000020612 ready-to-feed formula Nutrition 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000001223 reverse osmosis Methods 0.000 description 1
229960002477 riboflavin Drugs 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
229940100486 rice starch Drugs 0.000 description 1
150000003839 salts Chemical group 0.000 description 1
230000036186 satiety Effects 0.000 description 1
235000019627 satiety Nutrition 0.000 description 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
239000011669 selenium Substances 0.000 description 1
229910052711 selenium Inorganic materials 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
239000008347 soybean phospholipid Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
229960004274 stearic acid Drugs 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000001502 supplementing effect Effects 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
229960003080 taurine Drugs 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
235000019155 vitamin A Nutrition 0.000 description 1
239000011719 vitamin A Substances 0.000 description 1
235000019163 vitamin B12 Nutrition 0.000 description 1
239000011715 vitamin B12 Substances 0.000 description 1
235000019164 vitamin B2 Nutrition 0.000 description 1
239000011716 vitamin B2 Substances 0.000 description 1
235000019158 vitamin B6 Nutrition 0.000 description 1
239000011726 vitamin B6 Substances 0.000 description 1
235000019154 vitamin C Nutrition 0.000 description 1
239000011718 vitamin C Substances 0.000 description 1
235000019166 vitamin D Nutrition 0.000 description 1
239000011710 vitamin D Substances 0.000 description 1
150000003710 vitamin D derivatives Chemical class 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
229940046009 vitamin E Drugs 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
235000019168 vitamin K Nutrition 0.000 description 1
239000011712 vitamin K Substances 0.000 description 1
150000003721 vitamin K derivatives Chemical class 0.000 description 1
229940045997 vitamin a Drugs 0.000 description 1
229940011671 vitamin b6 Drugs 0.000 description 1
229940046008 vitamin d Drugs 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
229940046010 vitamin k Drugs 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Chemical & Material Sciences (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pediatric Medicine (AREA)
Dairy Products (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

NO20015178A 1999-04-29 2001-10-23 Sammensetning, morsmelkerstatning samt fremgangsmate og anvendelse av nevnte sammensetning. NO324312B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP99108405A EP1048226B1 (fr)	1999-04-29	1999-04-29	Aliment pour nourrissons comprenant une protéine de petit lait doux
GBGB9923048.4A GB9923048D0 (en)	1999-09-29	1999-09-29	Composition comprising casein protein and whey protein
PCT/EP2000/003887 WO2001011990A1 (fr)	1999-04-29	2000-05-02	Composition a faible teneur en threonine destinee a une formule pour enfant

Publications (3)

Publication Number	Publication Date
NO20015178L NO20015178L (no)	2001-10-23
NO20015178D0 NO20015178D0 (no)	2001-10-23
NO324312B1 true NO324312B1 (no)	2007-09-24

Family

ID=26152984

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20015178A NO324312B1 (no)	1999-04-29	2001-10-23	Sammensetning, morsmelkerstatning samt fremgangsmate og anvendelse av nevnte sammensetning.

Country Status (10)

Country	Link
US (1)	US6777391B1 (fr)
CN (1)	CN100413423C (fr)
AU (1)	AU765986B2 (fr)
BR (1)	BR0010125A (fr)
CA (1)	CA2371696C (fr)
MX (1)	MXPA01010778A (fr)
NO (1)	NO324312B1 (fr)
PL (1)	PL199861B1 (fr)
RU (1)	RU2275041C2 (fr)
WO (1)	WO2001011990A1 (fr)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9923048D0 (en) *	1999-09-29	1999-12-01	Nestle Sa	Composition comprising casein protein and whey protein
AU2002216479A1 (en) *	2000-12-08	2002-06-18	Tatua Co-Operative Dairy Company Limited	Isolation method
ES2326481T3 (es) *	2003-06-23	2009-10-13	Nestec S.A.	Formula para recien nacidos o formula de continuacion.
DE60323489D1 (de)	2003-09-12	2008-10-23	Nestec Sa	Fraktionen und Zubereitungen aus Milch zur Behandlung und / oder Vorbeugung COX-2 vermittelter Krankheiten
JP4509114B2 (ja)	2003-09-18	2010-07-21	アルラ・フーズ・エイ・エム・ビィ・エイ	幼児用調製乳
US20050118235A1 (en) *	2003-12-02	2005-06-02	Shiguang Yu	Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake
EP1634599A1 (fr)	2004-08-20	2006-03-15	N.V. Nutricia	Aliment infantile à activité immunostimulatrice
WO2006069918A1 (fr) *	2004-12-27	2006-07-06	Nestec S.A.	Utilisation d’une preparation pour nourrissons a teneur proteique reduite
EP1680967A1 (fr) *	2005-01-14	2006-07-19	Forum Media Productions SPRL	Compositions diététiques à base d'isolat de protéines solubles de lait
WO2006108824A1 (fr)	2005-04-13	2006-10-19	Nestec S.A.	Composition pour enfants en bas age comprenant des probiotiques
US20060286208A1 (en) *	2005-06-01	2006-12-21	Nagendra Rangavajla	Methods for producing protein partial hydrolysates and infant formulas containing the same
US7618669B2 (en) *	2005-06-01	2009-11-17	Mead Johnson Nutrition Company	Low-lactose partially hydrolyzed infant formula
US20070166411A1 (en) *	2005-12-16	2007-07-19	Bristol-Myers Squibb Company	Nutritional supplement containing long-chain polyunsaturated fatty acids
EP1962617A2 (fr) *	2005-12-23	2008-09-03	N.V. Nutricia	Compositions nutritionnelles destinees a prevenir l'obesite
BRPI0706795A2 (pt) *	2006-01-31	2011-04-05	Nestec Sa	composição nutricional para bebês com baixo peso de nascimento
PT1996031E (pt) *	2006-03-23	2009-12-16	Nutricia Nv	Fórmula para recém-nascido pré-termo
EP2003989A1 (fr) *	2006-03-31	2008-12-24	DSMIP Assets B.V.	Procédé d'hydrolyse de protéines de lait
LT5581B (lt) *	2007-11-10	2009-07-27	Vytautas FEDARAVIČIUS	Baltyminio pieno produkto su l-argininu gamybos būdas
UA103180C2 (ru)	2007-11-26	2013-09-25	Нестек С.А.	Сбалансированная по возрасту система питания для детей
US9131721B2 (en) *	2007-12-04	2015-09-15	Nestec S.A.	Gut microbiota in infants
KR20110058858A (ko) *	2008-08-29	2011-06-01	발리오 리미티드	락토오스 저함유 및 락토오스 무함유 유제품 및 그의 제조 방법
US8498729B2 (en) *	2008-08-29	2013-07-30	Smp Logic Systems Llc	Manufacturing execution system for use in manufacturing baby formula
US8986768B2 (en)	2008-08-29	2015-03-24	Valio Ltd.	Low-lactose and lactose-free milk product and process for production thereof
JP2012522505A (ja) *	2009-04-03	2012-09-27	ネステクソシエテアノニム	ミルク様飲料
EP2251032A1 (fr)	2009-05-12	2010-11-17	Nestec S.A.	Lactoferrine et santé mentale et protection chez adultes
EP2251029A1 (fr)	2009-05-12	2010-11-17	Nestec S.A.	Lactoferrine et santé neuronale de l'intestin chez les adultes et/ou les personnes âgées
EP2251030A1 (fr)	2009-05-12	2010-11-17	Nestec S.A.	Lactoferrine et santé mentale et développement chez les enfants
EP2251031A1 (fr)	2009-05-12	2010-11-17	Nestec S.A.	Lactoferrine et santé neuronale et développement dans l'intestin d'un enfant
AU2010329990B2 (en)	2009-12-08	2015-07-16	Nestec S.A.	Infant formula with probiotics and milk fat globule membrane components
RU2438343C1 (ru) *	2010-10-18	2012-01-10	Закрытое Акционерное Общество "Валетек Продимпэкс"	Сухая белковая смесь для приготовления коктейля для беременных и кормящих женщин
US20120171328A1 (en)	2011-01-05	2012-07-05	Dattatreya Banavara	Composition comprising heat labile milk proteins and process for preparing same
EP2514435A1 (fr) *	2011-04-19	2012-10-24	Nestec S.A.	Formule infantile à utiliser pour la prévention des maladies cardiovasculaires
US8183227B1 (en)	2011-07-07	2012-05-22	Chemo S. A. France	Compositions, kits and methods for nutrition supplementation
US8168611B1 (en)	2011-09-29	2012-05-01	Chemo S.A. France	Compositions, kits and methods for nutrition supplementation
EP2814335A4 (fr) *	2012-02-16	2015-03-25	Nestec Sa	Procédés de fabrication de boissons de type lait
KR102143027B1 (ko) *	2013-02-12	2020-08-11	엘스 뉴트리션 지에이치 엘티디	비-낙농 조제식
AU2014314537B2 (en)	2013-09-02	2019-08-15	Société des Produits Nestlé S.A.	Lactoferrin and memory and learning speed in children
CN103598353B (zh) *	2013-11-07	2015-11-18	河北三元食品有限公司	乳基无乳糖婴儿配方粉
ES2729757T3 (es) *	2013-11-29	2019-11-06	Nestle Sa	Uso de composiciones nutritivas que tienen un reducido contenido de proteínas
EP3079485B2 (fr)	2013-12-13	2022-03-30	Société des Produits Nestlé S.A.	Utilisation d'un lactosérum doux modifié et de lait maternisé contenant du lactosérum doux modifié pour favoriser le développement post-natal du système nerveux central et des fonctions cognitives associées de nourrissons
RU2717339C2 (ru)	2013-12-13	2020-03-23	Сосьете Де Продюи Нестле С.А.	Применение содержащей сладкую молочную сыворотку детской смеси для обеспечения постнатального развития нервной системы желудочно-кишечного тракта младенца и формирования функций кишечника, которыми она управляет
BR112016018954B1 (pt)	2014-03-24	2022-09-06	Carl Zeiss Vision Inc.	Método e sistema de otimização da geometria de pelo menos uma lente oftálmica semiacabada em um conjunto de lentes oftálmicas semiacabadas, código de programa informático, meio tangível de suporte informático legível e sinal de dados
WO2015154256A1 (fr) *	2014-04-09	2015-10-15	Nestle (China) Ltd.	Compositions nutritionnelles synthétiques spécifiques du sexe et systèmes nutritionnels les comprenant
WO2015154257A1 (fr) *	2014-04-09	2015-10-15	Nestle (China) Ltd.	Compositions nutritionnelles de synthèse sexospécifiques et systèmes nutritionnels les comprenant
WO2015154259A1 (fr) *	2014-04-09	2015-10-15	Nestle (China) Ltd.	Compositions nutritionnelles de synthèse sexospécifiques et systèmes nutritionnels les comprenant
RU2582264C1 (ru) *	2015-04-07	2016-04-20	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Омский государственный аграрный университет имени П.А. Столыпина"	Способ производства белкового кисломолочного продукта
CN108366601A (zh)	2015-12-14	2018-08-03	雀巢产品技术援助有限公司	促进大脑髓鞘形成的营养组合物和婴儿配方食品
WO2017102719A1 (fr)	2015-12-14	2017-06-22	Nestec S.A.	Compositions nutritionnelles et préparations pour nourrissons permettant de favoriser la myélinisation dans le cerveau
AU2016374161A1 (en)	2015-12-14	2018-04-19	Nestec S.A.	Nutritional compositions and infant formulas to promote myelination in the brain
CN119699586A (zh)	2015-12-14	2025-03-28	雀巢产品有限公司	促进大脑髓鞘形成的营养组合物和婴儿配方食品
AU2016374163A1 (en)	2015-12-14	2018-04-26	Nestec S.A.	Nutritional compositions and infant formulas to promote myelination in the brain
US11122833B1 (en)	2016-02-26	2021-09-21	Michelle Ann Toothman	Infant formulas having vitamin complexes with enhanced bioavailability
US10039805B1 (en)	2016-02-26	2018-08-07	Michelle Ann Toothman	Infant formulas having vitamin complexes with enhanced bioavailability
US10617700B1 (en)	2016-02-26	2020-04-14	Michelle Ann Toothman	Vitamin supplement compositions with enhanced bioavailability
CA3004044A1 (fr)	2016-03-30	2017-10-05	Nestec S.A.	Compositions comprenant des mineraux et leur utilisation
CA3003651A1 (fr)	2016-03-30	2017-10-05	Nestec S.A.	Compositions comprenant des acides gras et leur utilisation
WO2017167898A2 (fr)	2016-03-30	2017-10-05	Nestec S.A.	Compositions et leur utilisation
MX2018008519A (es)	2016-03-30	2018-08-16	Nestec Sa	Composiciones que comprenden vitaminas y su uso.
BR112018011380A2 (pt)	2016-03-30	2018-12-04	Nestec Sa	composições que compreendem fosfolipídeo e uso das mesmas
SG11201803026RA (en)	2016-03-30	2018-05-30	Nestec Sa	Compositions comprising choline and their use
WO2019092021A1 (fr)	2017-11-09	2019-05-16	Nestec S.A.	Ensemble de formules nutritionnelles adaptées à l'âge pour nourrissons et jeunes enfants, destiné à être utilisé dans la prévention d'une constitution corporelle sous-optimale
BR112020012263A2 (pt) *	2018-01-16	2020-11-24	Frieslandcampina Nederland B.V.	método de fornecimento de uma composição nutricional hipoalergênica para bebês que correm o risco de desenvolver alergia ao leite de vaca, composição nutricional hipoalergênica para bebês, método para limpar um hidrolisado parcial de proteína(s) do leite de um ou mais componentes capazes de se ligarem ao rage e/ou que possuem a capacidade de induzir a desgranulação de basófilos, e, hidrolisado parcial de proteína(s) do leite.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4303692A (en) *	1978-11-22	1981-12-01	Gaull Gerald E	Infant milk formula
EP0312612B1 (fr) *	1987-05-01	1993-03-24	Otsuka Pharmaceutical Co., Ltd.	Emulsion nutritive
FI904074A7 (fi) *	1989-08-28	1991-03-01	Milupa Ag	Optimoidun aminohappokoostumuksen omaavat proteiini-, peptidi- ja aminohapposeokset sekä niiden käyttö keskosten ja rintalasten ravinnon sekä äidinmaidon lisäaineiden valmistamiseksi
US5221668A (en) *	1992-02-26	1993-06-22	Abbott Laboratories	Nutritional product for trauma and surgery patients
US5405637A (en) *	1993-06-30	1995-04-11	Bristol-Myers Squibb Company	Milk protein partial hydrolysate and infant formula containing same
US5719133A (en) *	1994-09-21	1998-02-17	Novartis Nutrition Ag	Adolescent dietary composition
US5728678A (en)	1995-06-06	1998-03-17	Nestec Ltd.	Method and composition for providing nutrition to a renal failure patient
EP0880902A1 (fr)	1997-05-27	1998-12-02	Nestlé Produkte AG	Procédé de traitement d'une matiére première lactosérique

2000
- 2000-05-02 US US10/019,848 patent/US6777391B1/en not_active Expired - Lifetime
- 2000-05-02 WO PCT/EP2000/003887 patent/WO2001011990A1/fr not_active Ceased
- 2000-05-02 PL PL351599A patent/PL199861B1/pl unknown
- 2000-05-02 RU RU2001132152/13A patent/RU2275041C2/ru active
- 2000-05-02 MX MXPA01010778A patent/MXPA01010778A/es active IP Right Grant
- 2000-05-02 CN CNB008095434A patent/CN100413423C/zh not_active Expired - Lifetime
- 2000-05-02 BR BR0010125-7A patent/BR0010125A/pt not_active Application Discontinuation
- 2000-05-02 AU AU47535/00A patent/AU765986B2/en not_active Expired
- 2000-05-02 CA CA002371696A patent/CA2371696C/fr not_active Expired - Fee Related
2001
- 2001-10-23 NO NO20015178A patent/NO324312B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU765986B2 (en)	2003-10-09
CN100413423C (zh)	2008-08-27
RU2275041C2 (ru)	2006-04-27
CN1358067A (zh)	2002-07-10
NO20015178L (no)	2001-10-23
PL199861B1 (pl)	2008-11-28
AU4753500A (en)	2001-03-13
CA2371696C (fr)	2005-11-15
CA2371696A1 (fr)	2001-02-22
WO2001011990A1 (fr)	2001-02-22
MXPA01010778A (es)	2003-08-20
US6777391B1 (en)	2004-08-17
PL351599A1 (en)	2003-05-05
NO20015178D0 (no)	2001-10-23
BR0010125A (pt)	2002-01-15

Legal Events

Date	Code	Title	Description
2012-12-27	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO324312B1 (no)	2007-09-24	Sammensetning, morsmelkerstatning samt fremgangsmate og anvendelse av nevnte sammensetning.
US7776332B1 (en)	2010-08-17	Composition comprising casein protein and whey protein
AU771010B2 (en)	2004-03-11	Infant formula with improved protein content
CN103491973B (zh)	2016-09-14	用于预防心血管疾病的婴儿配方产品
RU2507863C2 (ru)	2014-02-27	Способ снижения горечи и улучшения вкуса свободной от белка гидролизованной смеси для детского питания
NO322739B1 (no)	2006-12-04	Enteral ernaeringssammensetning tilsiktet a fremme vekst og modning av lite utviklede gastro-intestinalkanaler hos unge pattedyr, og anvendelse.
EP1048226B1 (fr)	2005-08-31	Aliment pour nourrissons comprenant une protéine de petit lait doux
Crowley et al.	2017	Potential applications of non‐bovine mammalian milk in infant nutrition
JPWO2018221526A1 (ja)	2020-04-02	栄養組成物
HK1032887B (en)	2006-04-21	Infant formula containing sweet whey protein
JP2023069186A (ja)	2023-05-18	栄養組成物、栄養組成物の製造方法、及び栄養組成物中の銅の生体利用性の評価方法